These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7057032)

  • 21. Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
    Mattes MJ; Sharrow SO; Herberman RB; Holden HT
    J Immunol; 1979 Dec; 123(6):2851-60. PubMed ID: 387876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cells responsible for murine natural cytotoxic (NC) activity: a multi-lineage system.
    Bykowsky MJ; Stutman O
    J Immunol; 1986 Aug; 137(4):1120-6. PubMed ID: 3734456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
    Wayner EA; Brooks CG
    J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L; Lemieux S
    J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during Coxsackievirus B-3 infection.
    Huber SA; Job LP; Auld KR; Woodruff JF
    J Immunol; 1981 Apr; 126(4):1336-40. PubMed ID: 7204968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
    Herbert AG; Le Gros GS; Bidawid S; Watson JD
    Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
    J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter.
    Tam MR; Emmons SL; Pollack SB
    J Immunol; 1980 Feb; 124(2):650-5. PubMed ID: 6985934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous cytotoxic T cells in murine spleen-cell cultures. II. Distinguishing between spontaneous cytotoxic T cells and NK cells according to kinetics and target selectivity.
    Ezaki T; Skinner MA; Marbrook J
    Immunology; 1983 Nov; 50(3):351-7. PubMed ID: 6605302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine NK cell heterogeneity: subpopulations of C57BL/6 splenic NK cells detected by NK-1.1 and NK-2.1 antisera.
    Emmons SL; Pollack SB
    Nat Immun Cell Growth Regul; 1985; 4(4):169-77. PubMed ID: 4069121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1984 Apr; 51(4):719-26. PubMed ID: 6608487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased natural killer-type activity of spleen cells against immature thymocytes in autoimmune strains of mice.
    Granberg SC; Patel MR; Linna TJ
    Nat Immun Cell Growth Regul; 1985; 4(4):178-83. PubMed ID: 3877865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI; Holbrook NJ; Friedman H
    J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
    Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
    J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partially restorative role of T cells for low interleukin 2 dependent growth of NK cell progenitors from nude mice.
    Riccardi C; Migliorati G; Herberman RB
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):7-21. PubMed ID: 6235449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenocytes cultured in low concentrations of IL-2 generate NK cell specificities toward syngenic and allogenic targets.
    Nissen MH; Jeppesen M; Claesson MH
    Cell Immunol; 2000 Jul; 203(1):47-54. PubMed ID: 10915561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.